KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesDividends payablesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOther Accumulated ExpensesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abbott Laboratories (ABT) Other Non-Current Assets (2016 - 2020)

Abbott Laboratories (ABT) has disclosed Other Non-Current Assets for 12 consecutive years, with $824.0 million as the latest value for Q4 2020.

  • Quarterly Other Non-Current Assets rose 19.94% to $824.0 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $824.0 million through Dec 2020, up 19.94% year-over-year, with the annual reading at $824.0 million for FY2020, 19.94% up from the prior year.
  • Other Non-Current Assets hit $824.0 million in Q4 2020 for Abbott Laboratories, up from $687.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $2.8 billion in Q3 2016 to a low of $12.0 million in Q3 2018.
  • Historically, Other Non-Current Assets has averaged $683.4 million across 5 years, with a median of $294.5 million in 2016.
  • Biggest five-year swings in Other Non-Current Assets: soared 130550.0% in 2016 and later plummeted 97.95% in 2017.
  • Year by year, Other Non-Current Assets stood at $513.0 million in 2016, then plummeted by 96.1% to $20.0 million in 2017, then skyrocketed by 2815.0% to $583.0 million in 2018, then rose by 17.84% to $687.0 million in 2019, then grew by 19.94% to $824.0 million in 2020.
  • Business Quant data shows Other Non-Current Assets for ABT at $824.0 million in Q4 2020, $687.0 million in Q4 2019, and $583.0 million in Q4 2018.